PBX3 and pancreatic neoplasm: MiR-129-5p is also a tumor suppressor in pancreatic cancer, and it is reported that miR-129-5p exerts a tumor-suppressive effect in pancreatic cancer progression via targeting PBX3 (Qiu et al., 2019).